We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Sekisui Diagnostics UK Ltd.

Download Mobile App




Near-Infrared Dye Could Highlight Cancer Locations

By HospiMedica International staff writers
Posted on 10 Jan 2016
Print article
Image: Artist’s image of resolved blood vessels in the forelimb and brain (Photo courtesy of Alexander Antaris/ Stanford University).
Image: Artist’s image of resolved blood vessels in the forelimb and brain (Photo courtesy of Alexander Antaris/ Stanford University).
A novel medical dye emits light at the near-infrared (NIR) wavelength, helping surgeons detect hard-to-find tumors.

Under development by researchers at Stanford University (CA, USA), the small-molecule fluorophore dye emits light in a portion of the NIR range known as the second window, or NIR-II. Dyes emitting light in that range have long wavelengths, allowing researchers to probe tissues at centimeter depths, as well as achieve micrometer-scale resolution at millimeter depth. But while all currently approved NIR-II fluorophores are excreted slowly from the reticuloendothelial system, the new dye is rapidly eliminated, with about 90% excreted through the kidneys within 24 hours.

In laboratory tests in mice, the fluorophore, which is based on CH1055 (a synthetic 970-Da organic molecule), outperformed indocyanine green in resolving lymphatic vasculature and sentinel lymphatic mapping near a tumor. High levels of uptake of were observed in brain tumors in the mice, suggesting that the dye could be detected at a depth of about four mm. The dye succeeded in resolving blood vessels in the forelimb as well as the peripheral brain with high clarity, but also provided clear resolution of tumors in the center of the mouse's brain.

The CH1055 dye also allows targeted molecular imaging of tumors in vivo when conjugated with an antibody. According to the researchers, this could in the future prove to be an invaluable surgical tool, since the dye provides a superior tumor-to-background signal ratio, and thus could allow precise image-guided real-time excision surgery. The study describing the NIR-II fluorophore and the mouse experiments was published on November 23, 2015, in Nature Materials.

“The difficulty is how to make a dye that is both fluorescent in the infrared and water soluble. A lot of dyes can glow but are not dissolvable in water, so we can't have them flowing in human blood. Making a dye that is both is really the difficulty,” said lead author graduate student Alex Antaris, MSc. “We struggled for about three years or so and finally we succeeded. What's more, the new dye produces images that are sharper and more detailed than before, increasing their potential value to medicine and surgery.”

Related Links:

Stanford University


Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Silver Member
Wireless Mobile ECG Recorder
NR-1207-3/NR-1207-E
New
Baby Warmer
THERMOCARE Convenience

Print article

Channels

Patient Care

view channel
Image: The newly-launched solution can transform operating room scheduling and boost utilization rates (Photo courtesy of Fujitsu)

Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization

An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The Quantra Hemostasis System has received US FDA special 510(k) clearance for use with its Quantra QStat Cartridge (Photo courtesy of HemoSonics)

Critical Bleeding Management System to Help Hospitals Further Standardize Viscoelastic Testing

Surgical procedures are often accompanied by significant blood loss and the subsequent high likelihood of the need for allogeneic blood transfusions. These transfusions, while critical, are linked to various... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.